Jon Faiz Kayyem Insider Trades
DirectorDirector at Inhibrx Biosciences, Inc.. 3 significant open-market trades reported on SEC Form 4 in the last 180 days.
On EDGAR, this filer has 121 Form 4 filings on record since 2007, the latest on Sep 23, 2026. Full history on sec.gov
$1.6M
Bought
$0
Sold
3 / 0
Buys / Sells
1
Companies
Companies
- INBXDirector
Inhibrx Biosciences, Inc.
3 buys, $1.6M · 4 alerts in our log
Reported Trades
Open-market transactions only (code P and S), outside any 10b5-1 plan, dated by the day the filing reached EDGAR. Each row links to the filing.
Other Insiders at These Companies
Everyone else who reported a significant open-market trade at the same company in the last 180 days. Several insiders buying at once is cluster buying.
- Mark LappeCEO at INBX3 buys, $4.5M
- Douglas ForsythDirector at INBX1 buy, $287K
How to Read This Page
These are the trades an insider chose to make with their own money, not grants, option exercises or tax withholding. A purchase is the stronger signal (why buys carry more information than sales), and an insider who buys is locked out of selling for six months by the short-swing rule. The window here is 180 days; the full filing history lives on EDGAR.
Get this insider's next buy when it files
InsiderWatch reads every Form 4 as it reaches EDGAR, keeps the open-market buys that matter, and sends them by email and Telegram.
Try free for 7 daysEvery alert we send is logged with its timestamp and source.